Clinical Fellow, Department of HBP Surgery, Severance Hospital, Seoul, Korea
Research Fellow, Department of Pathology, Yonsei University College of Medicine
Postdoctoral Fellow, Department of Systems Biology, University of Texas MD Anderson Cancer Center, USA
Associate Professor, Department of Surgery, CHA University School of Medicine, Seongnam, Korea
논문
7-1. Lee, S. H. et al (2024). Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial. Clinical and molecular hepatology, 30(4), 807. (IF=14.0)
7-2. Lee, S. H. et al (2024). Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer. Journal of Translational Medicine, 22(1), 453. (IF=6.1)
7-3. Lee, S. H. et al (2023). Clinically conserved genomic subtypes of gastric adenocarcinoma. Molecular Cancer, https://doi.org/10.1186/s12943-023-01796-w (IF=37.3)
7-4. Lee, S. H. et al (2023). High serum IL-6 correlated with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma. JHEP Reports, 100672. (IF=8.3)
7-5. Lee, S. H., Yim, S. Y., Jeong, Y. S., Li, Q. X., Kang, S. H., Sohn, B. H., ... & Lee, J. S. (2022). Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. Hepatology, https://doi.org/10.1002/hep.32490 (IF=13.5)
7-6. Lee, S. H., Jeong, Y. S., Lee, S., & Lee, J. S. (2022). Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials. Cancer communications, https://doi.org/10.1002/cac2.12251 (IF=16.2)
7-7. Lee, S. H., Hwang, H. K., Lee, W. J., & Kang, C. M. (2021). MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer. Cellular Oncology, 44(6), 1363-1371. (IF=6.6)
7-8. Lee, S. H., Simoneau, E. B., Karpinets, T., Futreal, P. A., Zhang, J., Javle, M., ... & Chun, Y. S. (2021). Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations. Carcinogenesis, 42(3), 436-441. (IF=4.7)
7-9. Lee, S. H., Hwang, H. K., Lee, W. J., & Kang, C. M. (2019). Preoperative metabolic tumor volume2.5 associated with early systemic metastasis in resected pancreatic cancer: a transcriptome-wide analysis. Gut and liver, 13(3), 356. (IF=3.4)
7-10. Lee, S. H., Park, S. A., Zou, Y., Seo, S. U., Jun, C. D., Lee, W. J., ... & Cho, N. H. (2018). Real-Time Monitoring of cancer cells in live Mouse Bone Marrow. Frontiers in immunology, 9, 1681. (IF=7.3)
저서/역서/편서
Molecular Subtypes and Genomic Signatures of Hepatocellular Carcinoma for Prognostication and Therapeutic Decision-Making (Humana Press)